Literature DB >> 3818979

Pulmonary adenocarcinoma: review of 106 cases and proposed new classification.

C W Edwards.   

Abstract

The gross and microscopic appearances of 106 resected pulmonary adenocarcinomas were reviewed and correlated with postoperative survival. Instead of using an established classification based on histological pattern, the tumours were categorised by cellular morphology and site as either parenchymal adenocarcinoma (67%), bronchial adenocarcinoma (13%), or adenocarcinoma of uncertain origin (20%). Despite their pleomorphic appearance parenchymal adenocarcinomas should be regarded as a single entity, derived from multipotential cells of the distal airway; bronchial adenocarcinomas were generally, but not invariably, associated with short postoperative survival; those tumours that could not be reclassified on histological grounds were large adenocarcinomas consisting mainly of mucus cells. Tumours of this type carry a poor prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3818979      PMCID: PMC1140854          DOI: 10.1136/jcp.40.2.125

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Osteoplastic thoracoplasty.

Authors:  R BROCK
Journal:  Thorax       Date:  1955-03       Impact factor: 9.139

Review 2.  The respiratory epithelium. V. Histogenesis of lung carcinomas in the human.

Authors:  E M McDowell; J S McLaughlin; D K Merenyl; R F Kieffer; C C Harris; B F Trump
Journal:  J Natl Cancer Inst       Date:  1978-08       Impact factor: 13.506

3.  A histochemical and ultrastructural study of adenocarcinoma of the lung.

Authors:  Y Kimula
Journal:  Am J Surg Pathol       Date:  1978-09       Impact factor: 6.394

4.  Hyaline globules in human neoplasms. A report of three autopsy cases.

Authors:  A Dekker; J R Krause
Journal:  Arch Pathol       Date:  1973-03

5.  Site of origin, histogenesis, and cytostructure of bronchogenic carcinoma.

Authors:  J R Lisa; S Trinidad; M B Rosenblatt
Journal:  Am J Clin Pathol       Date:  1965-10       Impact factor: 2.493

6.  Clara cell carcinoma of the lung.

Authors:  A S Zolliker; J Jacques
Journal:  Hum Pathol       Date:  1981-08       Impact factor: 3.466

7.  Clara cell adenocarcinoma. Light and electron microscope studies.

Authors:  M Montes; J P Binette; A P Cahudhry; R H Adler; R Guarino
Journal:  Am J Surg Pathol       Date:  1977-09       Impact factor: 6.394

8.  The changing histopathology of lung cancer: a review of 1682 cases.

Authors:  R G Vincent; J W Pickren; W W Lane; I Bross; H Takita; L Houten; A C Gutierrez; T Rzepka
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

9.  Small cell squamous and mixed small cell squamous--small cell anaplastic carcinomas of the lung.

Authors:  A Churg; W H Johnston; M Stulbarg
Journal:  Am J Surg Pathol       Date:  1980-06       Impact factor: 6.394

10.  Atypical endocrine tumors of the lung.

Authors:  E M McDowell; T S Wilson; B F Trump
Journal:  Arch Pathol Lab Med       Date:  1981-01       Impact factor: 5.534

View more
  4 in total

1.  Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases.

Authors:  F A Carey; W A Wallace; R J Fergusson; K M Kerr; D Lamb
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

2.  Mesothelioma-like tumors of the pleura: a review of 72 autopsy cases.

Authors:  C A Hartmann; H Schütze
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Thyroid transcription factor 1 in pulmonary adenocarcinoma.

Authors:  G Stenhouse; N Fyfe; G King; A Chapman; K M Kerr
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

4.  A clinicopathologic analysis of microscopic extension in small cell lung cancer and lung adenocarcinoma: Determination of clinical target volume with precise radiotherapy.

Authors:  Liwei Gao; Xiuhong Wang; Xiongtao Yang; Runchuan Gu; Guangying Zhu; Xianshu Gao
Journal:  Thorac Cancer       Date:  2021-05-24       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.